Get the Stockscreener App
87.27
1.38%
-1.22
After Hours:
87.27
Overview
News
Price History
Option Chain
Financials
Discussions
Forecast
Stock Split
Dividend History
Medtronic Plc stock is traded at $87.27, with a volume of 6.21M.
It is down -1.38% in the last 24 hours and up +2.54% over the past month.
One of the largest medical-device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, transcatheter heart valves, stents, insulin pumps, spinal fixation devices, neurovascular products, advanced energy, and surgical tools. The company primarily markets its products to healthcare institutions and physicians in the United States, Western Europe, and Japan. Foreign sales account for roughly 50% of the company's total sales.
See More
Previous Close:
$88.49
Open:
$88.21
24h Volume:
6.21M
Relative Volume:
0.81
Market Cap:
$112.09B
Revenue:
$33.54B
Net Income/Loss:
$4.66B
P/E Ratio:
24.11
EPS:
3.62
Net Cash Flow:
$5.19B
1W Performance:
-0.19%
1M Performance:
+2.54%
6M Performance:
+5.81%
1Y Performance:
+6.87%
1-Day Range:
$87.08
$88.63
1-Week Range:
$86.38
$88.63
52-Week Range:
$75.96
$96.25
Medtronic Plc Stock (MDT) Company Profile
Name
Medtronic Plc
Sector
Industry
Phone
01135314381700
Address
BUILDING TWO PARKMORE BUSINESS PARK WEST, GALWAY
Compare MDT with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
MDT
Medtronic Plc
|
87.27 | 112.09B | 33.54B | 4.66B | 5.19B | 3.62 |
|
ABT
Abbott Laboratories
|
135.62 | 232.41B | 42.34B | 13.50B | 6.66B | 7.71 |
|
BSX
Boston Scientific Corp
|
99.74 | 151.04B | 17.55B | 2.03B | 2.72B | 1.37 |
|
SYK
Stryker Corp
|
377.30 | 146.71B | 23.22B | 2.86B | 3.58B | 7.40 |
|
EW
Edwards Lifesciences Corp
|
75.15 | 45.47B | 5.54B | 4.18B | 623.10M | 7.00 |
Medtronic Plc Stock (MDT) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-04-25 | Upgrade | Citigroup | Neutral → Buy |
| Oct-10-24 | Upgrade | RBC Capital Mkts | Sector Perform → Outperform |
| Aug-21-24 | Reiterated | Oppenheimer | Perform |
| Aug-15-24 | Upgrade | UBS | Sell → Neutral |
| Aug-14-24 | Downgrade | Stifel | Buy → Hold |
| May-30-24 | Initiated | Goldman | Sell |
| Jul-19-23 | Initiated | Robert W. Baird | Neutral |
| Jun-30-23 | Initiated | CL King | Buy |
| May-30-23 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Apr-24-23 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Mar-29-23 | Downgrade | UBS | Buy → Sell |
| Jan-09-23 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| Nov-23-22 | Downgrade | Citigroup | Buy → Neutral |
| Nov-23-22 | Downgrade | Oppenheimer | Outperform → Perform |
| Nov-16-22 | Downgrade | Deutsche Bank | Buy → Hold |
| Oct-18-22 | Initiated | Barclays | Equal Weight |
| Oct-13-22 | Initiated | Mizuho | Buy |
| Oct-12-22 | Initiated | Jefferies | Hold |
| Aug-24-22 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Jul-06-22 | Initiated | Wolfe Research | Underperform |
| Jun-01-22 | Downgrade | Atlantic Equities | Overweight → Neutral |
| May-27-22 | Downgrade | Needham | Buy → Hold |
| Apr-13-22 | Downgrade | Truist | Buy → Hold |
| Mar-02-22 | Resumed | BofA Securities | Buy |
| Jan-10-22 | Downgrade | BTIG Research | Buy → Neutral |
| Jan-07-22 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Jan-04-22 | Downgrade | Piper Sandler | Overweight → Neutral |
| Dec-17-21 | Downgrade | JP Morgan | Overweight → Neutral |
| Dec-16-21 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Dec-10-21 | Initiated | RBC Capital Mkts | Outperform |
| Jun-10-21 | Resumed | Cowen | Outperform |
| May-25-21 | Initiated | Barclays | Equal Weight |
| Apr-15-21 | Initiated | Atlantic Equities | Overweight |
| Dec-15-20 | Upgrade | Goldman | Sell → Neutral |
| Dec-15-20 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Oct-08-20 | Upgrade | Bernstein | Mkt Perform → Outperform |
| Oct-08-20 | Upgrade | Stifel | Hold → Buy |
| Sep-11-20 | Initiated | Wolfe Research | Peer Perform |
| May-14-20 | Downgrade | DZ Bank | Buy → Hold |
| Mar-30-20 | Downgrade | Needham | Strong Buy → Buy |
| Mar-25-20 | Upgrade | DZ Bank | Hold → Buy |
| Mar-05-20 | Initiated | Citigroup | Buy |
| Feb-13-20 | Initiated | Goldman | Sell |
| Jan-08-20 | Initiated | SunTrust | Buy |
| Jan-02-20 | Upgrade | Guggenheim | Neutral → Buy |
| Jun-05-19 | Upgrade | Wells Fargo | Market Perform → Outperform |
| Feb-04-19 | Reiterated | Needham | Strong Buy |
| Jan-03-19 | Initiated | Deutsche Bank | Buy |
| Jan-02-19 | Downgrade | Citigroup | Buy → Neutral |
| Dec-19-18 | Upgrade | JP Morgan | Neutral → Overweight |
| Nov-28-18 | Initiated | UBS | Buy |
| Oct-16-18 | Initiated | Barclays | Overweight |
| Aug-27-18 | Reiterated | Argus | Buy |
View All
Medtronic Plc Stock (MDT) Latest News
Limited Impact On Intuitive Surgical From Reprocessed Robotic Instruments: Analyst - Benzinga
Earnings Preview: What To Expect From Medtronic’s Report - MSN
Medtronic Diabetes Spinoff to Honor MiniMed Roots - Medical Device and Diagnostic industry
Medtronic (MDT) Revives MiniMed for Diabetes Spin-Off - GuruFocus
Medtronic recalls ventilators linked to 2 serious injuries, 1 death - MedTech Dive
Medtronic issues safety notice for Hugo surgical robot console in Europe - MassDevice
Medtronic separate diabetes business to be called MiniMed - Seeking Alpha
Medtronic announces MiniMed as name for planned New Diabetes Company - The Globe and Mail
Medtronic's New Diabetes Company to Be Named MiniMed - marketscreener.com
Medtronic (MDT) Unveils "MiniMed" for Upcoming Diabetes Spinoff - GuruFocus
Medtronic announces MiniMed as name for planned New Diabetes Company | MDT Stock News - GuruFocus
Medtronic names planned diabetes spinoff company MiniMed - Investing.com
Medtronic names planned diabetes spinoff company MiniMed By Investing.com - Investing.com Canada
Medtronic Announces MiniMed As Name For Planned New Diabetes Company - marketscreener.com
Medtronic Reveals MiniMed Name for $7B Diabetes Business Spinoff: What This Means for Healthcare Tech - Stock Titan
FDA Upgrades Medtronic Recall Of Newport Ventilators To Class I - RTTNews
Medtronic Q4 Earnings and Revenues Top, Stock Down in Pre-market - MSN
Medtronic advises discontinuation of certain Newport ventilators after recall - MassDevice
Medtronic : announces voluntary recall of select Newport™ HT70 and Newport™ HT70 Plus ventilators and certain related Newport™ service parts - marketscreener.com
Medtronic : treats first U.S. patient in Global SYMPLICITY Registry DEFINE Study - marketscreener.com
5 Things You Need to Know If You Buy Medtronic Today - The Motley Fool
Medtronic names Kate Benedict president of acute care and monitoring - MedTech Dive
Medtronic appoints new president of Acute Care & Monitoring unit - MassDevice
Medtronic Announces Intent To Spin Diabetes Business - Forbes
Medtronic wins CE mark for VitalFlow ECMO system - MassDevice
Medtronic to separate diabetes business, WSJ reports - MSN
Medtronic's Separation of Diabetes Business May Drive Long-Term Value, Needham Says - marketscreener.com
Medtronic removes tracheostomy tubes due to dislodging risk - MedTech Dive
NEEDHAM ANALYST MAINTAINS HOLD RATING ON MEDTRONIC STOCK By Investing.com - Investing.com UK
Medtronic (MDT) Rating Reiterated as Hold by Needham | MDT Stock News - GuruFocus
Medtronic shares uptick for eight consecutive sessions (NYSE:MDT) - Seeking Alpha
FDA Says Medtronic Had Removed Shiley Adult Flexible Tracheostomy Tube - marketscreener.com
Medtronic (MDT) Gains Amid Diabetes Division Spin-Off Plans - GuruFocus
Medtronic shares uptick for eight consecutive sessions - MSN
Medtronic Just Announced a Move That Its Shareholders Should Love - Yahoo Finance
Medtronic : receives FDA 510(k) clearance for Visualase™ V2 MRI-Guided Laser Ablation System - marketscreener.com
Is Medtronic Stock Underperforming The Dow? - Barchart.com
DBS Bank Adjusts Price Target on Medtronic to $82 From $90, Maintains Hold Rating - marketscreener.com
Goldman Sachs Adjusts Price Target on Medtronic to $78 From $85, Maintains Sell Rating - marketscreener.com
Medtronic Strengthens Return-to-Office Requirements for Hybrid Employees - Medical Device and Diagnostic industry
How Much Would It Take To Earn $100 A Month From Medtronic Stock - Benzinga
Medtronic (MDT) Sees Increased Bullish Options Activity | MDT Stock News - GuruFocus
Medtronic to spin off its diabetes businessreport - MSN
Medtronic is telling workers to return to the office more - MassDevice
The Strong Earnings Posted By Medtronic (NYSE:MDT) Are A Good Indication Of The Strength Of The Business - Yahoo Finance
Medtronic (NYSE:MDT) Will Pay A Larger Dividend Than Last Year At $0.71 - simplywall.st
Medtronic plc (MDT): A Bull Case Theory - MSN
Medtronic at Bernstein Conference: Strategic Focus on Growth and Innovation By Investing.com - Investing.com UK
Transcript : Medtronic plc Presents at Bernstein 41st Annual Strategic Decisions Conference 2025, May-29-2025 11 - marketscreener.com
Medtronic Splits, Boston Scientific Exits TAVR, J&J Loses Big - Medical Device and Diagnostic industry
Medtronic To Present At Bernstein's Strategic Decisions Conference; Webcast At 11:00 AM ET - Nasdaq
Medtronic Plc Stock (MDT) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.84%
1.20%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):